Literature DB >> 21801699

Nanotechnology for therapy and imaging of liver diseases.

L Harivardhan Reddy1, Patrick Couvreur.   

Abstract

Nanotechnology has been considered for the improved delivery of various therapeutic agents, including drugs and genes. Indeed, liposomes and nanoparticles equipped with homing devices for the targeting of receptors over-expressed on the hepatic tissue have improved the treatment of various liver diseases. In this review, various nanotechnology approaches employed for the treatment/imaging of liver disease, either in preclinical or in clinic are discussed.
Copyright © 2011 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21801699     DOI： 10.1016/j.jhep.2011.05.039

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


  29 in total

Review 1.  Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release.

Authors:  Nazila Kamaly; Basit Yameen; Jun Wu; Omid C Farokhzad
Journal:  Chem Rev       Date:  2016-02-08       Impact factor: 60.622

Review 2.  Nanomedicines in gastroenterology and hepatology.

Authors:  Alf Lamprecht
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-03-10       Impact factor: 46.802

Review 3.  Nanomedicines for renal disease: current status and future applications.

Authors:  Nazila Kamaly; John C He; Dennis A Ausiello; Omid C Farokhzad
Journal:  Nat Rev Nephrol       Date:  2016-10-31       Impact factor: 28.314

Review 4.  Challenges in liver cancer and possible treatment approaches.

Authors:  David Anwanwan; Santosh Kumar Singh; Shriti Singh; Varma Saikam; Rajesh Singh
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2019-11-01       Impact factor: 10.680

5.  Cellular distribution of injected PLGA-nanoparticles in the liver.

Authors:  Jin-Kyu Park; Teruo Utsumi; Young-Eun Seo; Yang Deng; Ayano Satoh; William Mark Saltzman; Yasuko Iwakiri
Journal:  Nanomedicine       Date:  2016-03-04       Impact factor: 5.307

Review 6.  Active radar guides missile to its target: receptor-based targeted treatment of hepatocellular carcinoma by nanoparticulate systems.

Authors:  Jing-Jun Yan; Jia-Zhi Liao; Ju-Sheng Lin; Xing-Xing He
Journal:  Tumour Biol       Date:  2014-11-26

Review 7.  Current and future directions in the treatment and prevention of drug-induced liver injury: a systematic review.

Authors:  Jonathan G Stine; James H Lewis
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2015-12-25       Impact factor: 3.869

Review 8.  Challenging the future of siRNA therapeutics against cancer: the crucial role of nanotechnology.

Authors:  Lígia Catarina Gomes-da-Silva; Sérgio Simões; João Nuno Moreira
Journal:  Cell Mol Life Sci       Date:  2013-11-13       Impact factor: 9.261

Review 9.  Applications of Nanobiomaterials in the Therapy and Imaging of Acute Liver Failure.

Authors:  Yuanyuan Jin; Haixia Wang; Ke Yi; Shixian Lv; Hanze Hu; Mingqiang Li; Yu Tao
Journal:  Nanomicro Lett       Date:  2020-11-19

10.  Crizotinib and Doxorubicin Cooperatively Reduces Drug Resistance by Mitigating MDR1 to Increase Hepatocellular Carcinoma Cells Death.

Authors:  Ming Shao; Run Shi; Zhen-Xing Gao; Shan-Shan Gao; Jing-Feng Li; Huan Li; Shu-Zhong Cui; Wei-Min Hu; Tian-Yun Chen; Gui-Ru Wu; Jie Zhang; Jiang Xu; Man-Sun Sy; Chaoyang Li
Journal:  Front Oncol       Date:  2021-05-18       Impact factor: 6.244
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.